BioViva Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $400K

BioViva General Information

Description

Developer of biotech company intended to offer precision-based medicines as per requirements and human needs. The company's proprietary CMV gene therapy platform supports the delivery of larger genetic payloads, enabling users to minimize the treatments by offering more genetic information.

Contact Information

Website
www.bioviva-science.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 6580 Northeast Honeysuckle Lane
  • Bainbridge Island, WA 98110
  • United States
+1 (206) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioViva Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 25-Dec-2022 $400K 00.000 Completed Generating Revenue
2. Equity Crowdfunding 000 00.000 Completed Startup
1. Angel (individual) 27-May-2015 $250K $250K Completed Startup
To view BioViva’s complete valuation and funding history, request access »

BioViva Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biotech company intended to offer precision-based medicines as per requirements and human needs. The compan
Biotechnology
Bainbridge Island, WA
12 As of 2022
00.000
000000000 00.000

000000

rem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor inc
0000000000000
Brisbane, CA
000 As of 0000
00000
000000000 00000

000000

m dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt
0000000000000
Plymouth Meeting, PA
000 As of 0000
000.00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioViva Competitors (65)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sangamo Therapeutics Formerly VC-backed Brisbane, CA 000 00000 000000000 00000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
000000 Formerly VC-backed Seattle, WA 00 00000 000000000 00000
000000000 Formerly VC-backed Gaithersburg, MD 00 00000 00000000 00000
0000000 000000 Formerly VC-backed New York, NY 000 00000 00000000 00000
You’re viewing 5 of 65 competitors. Get the full list »

BioViva Patents

  • 8

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 4

    Pending

  • 000

    Expiring in next 12 mo

BioViva Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220401583-A1 Treatment of age-related cognitive decline using genetically modified viral vectors Pending 16-Jun-2021 000000000 0
US-20220251603-A1 Systems and methods for gene therapy via administration of genetically modified viral vectors Pending 05-Feb-2021 000000000
US-20220177921-A1 Gene therapy using genetically modified viral vectors Pending 27-Aug-2018 0000000000
US-20200061210-A1 Novel method for gene therapy using intranasal administration of genetically modified viral vectors Inactive 27-Aug-2018 00000000000 0
US-11266721-B1 Methods of treating or preventing age related disorders Active 20-Apr-2016 A61K38/45
To view BioViva’s complete patent history, request access »

BioViva Executive Team (4)

Name Title Board Seat Contact Info
Elizabeth Parrish Co-Founder & Chief Executive Officer
Avi Roy Chief Technology Officer
Anca Selariu Ph.D Chief Scientific Officer
Jason Williams MD Co-Founder & Chief Medical Officer
To view BioViva’s complete executive team members history, request access »

BioViva Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial